Autoimmunity and mast cell-related diseases

References

• Christy AL, Brown MA. The multitasking mast cell: positive and negative roles in the progression of autoimmunity. J. Immunol.179(5), 2673–2679 (2007).
   PubMed Web of Science ®Google Scholar
• Metz M, Maurer M. Mast cells: key effector cells in immune responses. Trends Immunol.28(5), 234–241 (2007).
   PubMed Web of Science ®Google Scholar
• Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in allergy. Immunol. Allergy Clin. North Am.26(3), 407–425 (2006).
   PubMed Web of Science ®Google Scholar
• Galli SJ, Kitamura Y. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol.127(1), 191–198 (1987).
   PubMed Web of Science ®Google Scholar
• Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as ‘tunable’ effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol.23, 749–786 (2005).
   PubMed Web of Science ®Google Scholar
• Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol.6(2), 135–142 (2005).
   PubMed Web of Science ®Google Scholar
• Boseila AW, Toone EC Jr. Basophil leucocytes (blood mast cells) in rheumatoid arthritis. Acta Rheumatol. Scand.7, 183–190 (1961).
   PubMedGoogle Scholar
• Nigrovic PA, Lee D. Synovial mast cells: role in acute and chronic arthritis. Immunol. Rev.217, 19–37 (2007).
   PubMed Web of Science ®Google Scholar
• Mican JM, Metcalfe DD. Arthritis and mast cell activation. J. Allergy Clin. Immunol.86(4), 677–683 (1999).
   Google Scholar
• Monach P, Hattori K, Huang H et al. The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol. Med.36 (7), 269–282 (2007).
   Google Scholar
• Rottem M, Mekori YA. Mast cells and autoimmunity. Autoimmun. Rev.4(1), 21–27 (2005).
   PubMed Web of Science ®Google Scholar
• Kaieda S, Tomi C, Oki S et al. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthritis Rheum.56(6), 1836–1845 (2007).
   PubMedGoogle Scholar
• Shin K, Gurish MF, Friend DS et al. Lymphocyte-independent connective tissue mast cells populate murine synovium. Arthritis Rheum.54(9), 2863–2871 (2006).
   PubMedGoogle Scholar
• Zappulla JP, Arock M, Mars LT, Liblau RS. Mast cells: new targets for multiple sclerosis therapy? J. Neuroimmunol.131(1–2), 5–20 (2002).
   PubMedGoogle Scholar
• Secor VH, Secor WE, Gutekunst CA et al. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med.191(5), 813–822 (2000).
   PubMed Web of Science ®Google Scholar
• Robbie-Ryan M, Tanzola MB, Secor VH et al. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol.170(4), 1630–1634 (2003).
   PubMed Web of Science ®Google Scholar
• Gregory GD, Raju SS, Winandy S et al. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J. Clin. Invest.116(5), 1327–1336 (2006).
   PubMed Web of Science ®Google Scholar
• Tanzola MB, Robbie-Ryan M, Gutekunst CA et al. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol.171(8), 4385–4391 (2003).
   PubMed Web of Science ®Google Scholar
• Chen R, Fairley JA, Zhao ML et al. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage mediated neutrophil infiltration depends on mast cell activation. J. Immunol.169(7), 3987–3992 (2002).
   PubMed Web of Science ®Google Scholar
• Fairley JA, Burnett CT, Fu CL et al. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nunu/nu mice. J. Invest. Dermatol.127(11), 2605–2611 (2007).
   PubMed Web of Science ®Google Scholar
• Wallukat G, Wollenberger A. Autoantibodies to β 2-adrenergic receptors with antiadrenergic activity from patients with allergic asthma. J. Allergy Clin. Immunol.88(4), 581–587 (1991).
   PubMed Web of Science ®Google Scholar
• Nahm DH, Lee YE, Yim EJ et al. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am. J. Respir. Crit. Care Med.165(11), 1536–1539 (2002).
   PubMed Web of Science ®Google Scholar
• Tirosh A, Mandel D, Mimouni FB et al. Autoimmune diseases in asthma. Ann. Intern. Med.44(12), 877–883 (2006).
   Google Scholar
• Doutre MS. Chronic urticaria and thyroid auto-immunity. Clin. Rev. Allergy Immunol.30(1), 31–37 (2006).
   PubMed Web of Science ®Google Scholar
• Dreskin SC, Andrews KY. The thyroid and urticaria. Curr. Opin. Allergy Clin. Immunol.5(5), 408–412 (2005).
   PubMed Web of Science ®Google Scholar
• Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J. Allergy Clin. Immunol.84(1), 66–71 (1989).
   PubMed Web of Science ®Google Scholar
• Gruber BL, Baeza M, Marchese M et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J. Invest. Dermatol.90(2), 213–217 (1988).
   PubMed Web of Science ®Google Scholar
• Irani C, Gordon ND, Zweiman B et al. Chronic urticaria/angioedema and Graves’ disease: coexistence of 2 antireceptor antibody-mediated diseases. J. Allergy Clin. Immunol.108(5), 874 (1988).
   Google Scholar
• Asero R, Lorini M, Tedeschi A. Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies. J. Allergy Clin. Immunol.111(5), 1129–1130 (2003).
   PubMed Web of Science ®Google Scholar
• Asero R, Orsatti A, Tedeschi A et al. Autoimmune chronic urticaria associated with type 1 diabetes and Graves’ disease. J. Allergy Clin. Immunol.115(5), 1088–1089 (2005).
   PubMed Web of Science ®Google Scholar
• Mittermann I, Aichberger KJ, Bünder R et al. Autoimmunity and atopic dermatitis. Curr. Opin. Allergy Clin. Immunol.4(5), 367–371 (2004).
   PubMed Web of Science ®Google Scholar
• Valenta R, Maurer D, Steiner R et al. Immunoglobulin E responses to human proteins in atopic patients. J. Invest. Dermatol.107(2), 203–208 (1996).
   PubMed Web of Science ®Google Scholar
• Valenta R, Duchene M, Pettenburger C et al. Identification of profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals. Science253(5019), 557–560 (1991).
   PubMed Web of Science ®Google Scholar
• Kinaciyan T, Natter S, Kraft D et al. IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J. Allergy Clin. Immunol.109(4), 717–719 (2002).
   PubMed Web of Science ®Google Scholar
• Lisbonne M, Diem S, de Castro Keller A et al. Cutting edge: invariant V α-14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol.171(4), 1637–1641 (2003).
   PubMed Web of Science ®Google Scholar
• Meyer EH, Goya S, Akbari O et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl Acad. Sci. USA103(8), 2782–2787 (2006).
   PubMed Web of Science ®Google Scholar
• Akbari O, Faul JL, Hoyte EG et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med.354(11), 1117–1129 (2006).
   PubMed Web of Science ®Google Scholar
• Borg NA, Wun KS, Kjer-Nielsen L et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature448(7149), 44–49 (2007).
   PubMed Web of Science ®Google Scholar
• Oki S, Miyake S. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Allergol. Int.56(1), 7–14 (2007).
   PubMedGoogle Scholar
• Vijayanand P, Seumois G, Pickard C et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med.356(14), 1410–1422 (2007).
   PubMed Web of Science ®Google Scholar
• Meyer EH, Dekruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma. Annu. Rev. Med.18(59), 281–292 (2008).
   Google Scholar
• Ho LP. Natural killer T cells in asthma – toward increased understanding. N. Engl. J. Med.356(14), 1466–1468 (2007).
   PubMed Web of Science ®Google Scholar
• Mekori YA, Metcalfe DD. Mast cell–T cell interactions. J. Allergy Clin. Immunol.104(3), 517–523 (1999).
   PubMed Web of Science ®Google Scholar
• Biedermann T, Kneilling M, Mailhammer R et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med.192(10), 1441–1452 (2000).
   PubMed Web of Science ®Google Scholar
• Bhattacharyya SP, Drucker I, Reshef T et al. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J. Leukoc. Biol.63(3), 337–341 (1998).
   PubMed Web of Science ®Google Scholar
• Inamura N, Mekori YA, Bhattacharyya SP. Induction and enhancement of Fc(ε)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol.160(8), 4026–4033 (1998).
   PubMed Web of Science ®Google Scholar
• Malaviya R, Twesten NJ, Ross EA et al. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol.156(4), 1490–1496 (1996).
   PubMed Web of Science ®Google Scholar
• Mekori YA. The mastocyte: the ‘other’ inflammatory cell in immunopathogenesis. J. Allergy Clin. Immunol.114(1), 52–57 (2004).
   PubMed Web of Science ®Google Scholar
• Sayed BA, Brown MA. Mast cells as modulators of T-cell responses. Immunol. Rev.217, 53–64 (2007).
   PubMed Web of Science ®Google Scholar
• Lu LF, Lind EF, Gondek DC et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature442(7106), 997–1002 (2006).
   PubMed Web of Science ®Google Scholar
• Bryce PJ, Miller ML, Miyajima I et al. Oettgen immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity20(4), 381–392 (2004).
   PubMed Web of Science ®Google Scholar
• McIlroy A, Caron G, Blanchard S et al. Histamine and prostaglandin E2 up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-γ-induced CXCL10 production by immature human dendritic cells. Immunology117(4), 507–516 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol.120(2), 247–254 (2007).
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ et al. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity24(2), 179–189 (2006).
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med.201(2), 233–240 (2005).
   PubMed Web of Science ®Google Scholar
• Umetsu DT, Dekruyff RH. Immune dysregulation in asthma. Curr. Opin. Immunol.18(6), 727–732 (2006).
   PubMed Web of Science ®Google Scholar
• Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. Allergy Clin. Immunol.120(2), 227–235 (2007).
   Google Scholar
• Huan J, Culbertson N, Spencer L et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res.81(1), 45–52 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou B, Comeau MR, De Smedt T et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol.6(10), 1047–1053 (2005).
   PubMed Web of Science ®Google Scholar
• Allman D, Northrup D. Giving B cell tolerance the ‘TSLiP’. Nat. Immunol.8(5), 481–483 (2007).
   PubMed Web of Science ®Google Scholar
• Astrakhan A, Omori M, Nguyen T et al. Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development. Nat. Immunol.8(5), 522–531 (2007).
   PubMed Web of Science ®Google Scholar